Understanding these mechanisms helps explain why it shows particular promise for shoulder conditions specifically
The five classifications are: Class 1: enzyme deficiency with chronic nonspherocytic hemolytic anemia Class 2: severe enzyme deficiency, less than 10% of normal activity Class 3: moderate to mild enzyme deficiency, 10-60% of normal activity Class 4: very mild or no enzyme deficiency, at least 60% of normal activity Class 5: increased enzyme activity Pathogenic variants in the G6PD gene that result in non-spherocytic hemolytic anemia have all been found to cluster near the carboxy terminal end of the protein, whereas, the pathogenic variants that result in clinically mild symptoms are clustered near the amino terminal end of the protein
External or subjective effects are not yet visible
However, taking excessively high doses without medical guidance or combining it with unsafe skin-lightening agents could result in side effects
10.1016/0005-2744(80)90004-2 37 LahtiP
The peptide stimulates osteoblast activity via VEGFR2-nitric oxide signaling, enhancing bone matrix deposition
